Skip to main content
Clinical Trials/NCT03185676
NCT03185676CompletedNot Applicable

The Long Term Efficacy of a Bilberry-based Probiotic Product on Glucose Tolerance and Insulin Resistance as Compared to a Control.

Lund University1 site in 1 country32 target enrollmentStarted: May 2, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
32
Locations
1
Primary Endpoint
The long term effect of a bilberry-based probiotic beverage on postprandial levels of serum insulin

Study Overview

Brief Summary

The impact of a bilberry-based probiotic drink on the postprandial levels of serum glucose and insulin have already been study in the past. The aim of the current study is to evaluate the long term effect of the probiotic bilberry drink on glucose tolerance and insulin resistance in healthy adults and in comparison to a control drink.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Healthy adults with a BMI between 20-30

Exclusion Criteria

  • Not provided

Arms & Interventions

Billberry

Experimental

A bilberry-based probiotic beverage

Intervention: Bilberry (Other)

Control

Active Comparator

A control beverage without bilberries or probiotics

Intervention: beverage without bilberries or probiotics (Other)

Outcomes

Primary Outcomes

The long term effect of a bilberry-based probiotic beverage on postprandial levels of serum insulin

Time Frame: Incremental area under the curve for serum insulin from 0 min up to 120 min following the ingestion of the study product

The incremental area under the curve (AUC) will be measured for the levels of postprandial serum insuling from 0 min to 120 min following ingestion of the product (included intermediate measuring time points are 30, 60 and 90 min)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Åsa Håkansson

Associate Senior Lecturer

Lund University

Study Sites (1)

Loading locations...

Similar Trials